
Please try another search
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company’s lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California.
Name | Age | Since | Title |
---|---|---|---|
Ronald A. Martell | 61 | 2022 | President, CEO & Director |
Stephen J. Galli | 76 | 2023 | Member of Scientific Advisory Board |
Thomas G. Wiggans | 72 | 2023 | Independent Chairman |
Scott C. Brun | 55 | 2023 | Independent Director |
Harry Malech | - | - | Member of Scientific Advisory Board |
Judith Anne Shizuru | 68 | 2018 | Co-Founder, Member of Scientific Advisory Board & Director |
Svetlana Lucas | 52 | 2024 | Independent Director |
Joshua Boyce | - | 2025 | Member of Scientific Advisory Board |
Martin Metz | - | 2025 | Member of Scientific Advisory Board |
Dean Metcalfe | - | 2025 | Member of Scientific Advisory Board |
Lawrence Schwartz | - | 2025 | Member of Scientific Advisory Board |
Christian W. Nolet | 68 | 2021 | Independent Director |
Daniel C. Adelman | 68 | 2023 | Acting Chief Medical Officer, Member of Scientific Advisory Board & Senior Clinical Advisor |
Arthur Weiss | - | - | Member of Scientific Advisory Board |
Kurt von Emster | 58 | 2019 | Independent Director |
Jeffrey V. Ravetch | 74 | - | Member of Scientific Advisory Board |
Frederick R. Appelbaum | - | - | Member of Scientific Advisory Board |
Vishal Kapoor | 49 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review